Yousif Capital Management, LLC Eagle Pharmaceuticals, Inc. Transaction History

Yousif Capital Management, LLC

  • $8.96 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022
SELL
$26.42 - $47.12 $12,575 - $22,429
-476 Reduced 5.29%
8,522 $225,000
Q2 2022

Aug 01, 2022
SELL
$41.26 - $51.35 $52,606 - $65,471
-1,275 Reduced 12.41%
8,998 $400,000
Q1 2022

May 12, 2022
BUY
$44.58 - $52.6 $48,146 - $56,808
1,080 Added 11.75%
10,273 $508,000
Q4 2021

Jan 31, 2022
BUY
$45.82 - $56.9 $421,223 - $523,081
9,193 New
9,193 $468,000

Others Institutions Holding EGRX

# of Institutions
70
Shares Held
8.6M
Call Options Held
1M
Put Options Held
100
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email